Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure

AIM: Portal hypertension is a common complication of liver cirrhosis and significantly increases mortality and morbidity. Previous reports have suggested that the compound thalidomide attenuates portal hypertension (PHT). However, the mechanism for this action is not fully elucidated. One hypothesis...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:World J Gastroenterol
Egile Nagusiak: Theodorakis, Nicholas G, Wang, Yining N, Korshunov, Vyacheslav A, Maluccio, Mary A, Skill, Nicholas J
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Baishideng Publishing Group Inc 2015
Gaiak:
Basic Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4394073/
https://ncbi.nlm.nih.gov/pubmed/25892862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i14.4126
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak